Chemotherapeutic DNA-damaging drugs activate interferon regulatory factor-7 by the mitogen-activated protein kinase kinase-4-c-Jun NH2-terminal kinase pathway

Cancer Research

Volumn 60, Issue 5, 2000, Pages 1153-1156

  Kim, Tae Kook ^a,b   Kim, Taeil ^b   Kim, Tae Young ^b   Lee, Woo Ghil ^a   Yim, Jeongbin ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; DNA; DOXORUBICIN; ETOPOSIDE; INTERFERON REGULATORY FACTOR 7; MITOGEN ACTIVATED PROTEIN KINASE; MITOMYCIN; PROTEIN P53; RECOMBINANT GAMMA INTERFERON; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; DNA DAMAGE; ENZYME ACTIVITY; GENOTOXICITY; HELA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TUMOR CELL; TUMOR SUPPRESSOR GENE; ULTRAVIOLET IRRADIATION;

ANTINEOPLASTIC AGENTS; DNA DAMAGE; DNA-BINDING PROTEINS; GENES, P53; HELA CELLS; HUMANS; INTERFERON REGULATORY FACTOR-7; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; SIGNAL TRANSDUCTION;

EID: 0342980322     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Fisher, D. E. Apoptosis in cancer therapy: crossing the threshold. Cell, 78: 539-542, 1994.
2. Lowe, S. W., Bodis, S., Bardeesy, N., McClatchey, A., Remington, L., Ruley, H. E., Fisher, D. E., Jacks, T., Pelletier, J., and Housman, D. E. Apoptosis and the prognostic significance of p53 mutation. Cold Spring Harbor Symp. Quant. Biol., 59: 419-426, 1994.
3. Giaccia, A. J., and Kastan, M. B. The complexity of p53 modulation: emerging patterns from divergent signals. Genes Dev., 12: 2973-2983, 1998.
4. Hansen, R., and Oren, M. p53: from inductive signal to cellular effect. Curr. Opin. Genet. Dev., 7: 46-51, 1997.
5. Ko, L. J., and Prives, C. p53: puzzles and paradigm. Genes Dev., 10: 1054-1072, 1996.
6. Weinert, T. DNA damage and checkpoint pathways: molecular anatomy and interactions with repair. Cell. 94: 555-558, 1998.
7. Au, W. C., Moore, P. A., LaFleur, D. W., Tombal, B., and Pitha, P. M. Characterization of the interferon regulatory factor-7 and its potential role in the transcription activation of interferon A genes. J. Biol. Chem., 273: 29210-29217, 1998.
8. Marie, I., Durbin, J. E., and Levy, D. Differential viral induction of distinct interferon-α genes by positive feedback through interferon regulatory factor-7. EMBO J., 17: 6660-6669, 1998.
9. Sato, M., Hata, N., Asagiri, M., Nakaya, T., Taniguchi, T., and Tanaka, N. Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7. FEBS Lett., 441: 106-110, 1998.
10. Wathelet, M. G., Lin, C. H., Parekh, B. S., Ronco, L. V., Howley, P. M., and Maniatis, T. Virus infection induces the assembly of coordinately activated transcription factors on the IFN-β enhancer in vivo. Mol. Cell, I: 507-518, 1998.
11. Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1998.
12. Harlow, H., and Lane, D. Antibodies. A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1988.
13. Fritsche, M., Haessler, C., and Brandner, G. Induction of nuclear accumulation of the tumor-suppressor protein p53 by DNA-damaging agents. Oncogene, 8: 307-318, 1993.
14. Fanger, G. R., Gerwins, P., Widmann, C., Jarpe, M. B., and Johnson, G. L. MEKKs, GCKs, MLKs, PAKs, TAKs, and Tpls: upstream regulators of the c-Jun amino-terminal kinases? Curr. Opin. Genet. Dev., 7: 67-74, 1997.
15. Ip, Y. T., and Davis, R. J. Signal transaction by the c-Jun N-terminal kinase (JNK)-from inflammation to development. Curr. Opin. Cell Biol., 10: 205-219, 1998.
16. Karin, M. The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem., 270: 16483-16486, 1995.
17. Kyriakis, J. M., and Avruch, J. Sounding the alarm: protein kinase cascades activated by stress and inflammation. J. Biol. Chem., 271: 24313-24316, 1996.
18. Fuchs, S. Y., Adler, V., Pincus, M. R., and Ronai, Z. MEKK1/JNK signaling stabilizes and activates p53. Proc. Natl. Acad. Sci. USA, 95: 10541-10546, 1998.
19. Kharbanda, S., Ren, R., Pandey, P., Shafman, T. D., Feller, S. M., Weichselbaum, R. R., and Kufe, D. Activation of the c-Abl tyrosine kinase in the stress response to DNA-damaging agents. Nature (Lond.), 376: 785-788, 1995.
20. 2-terminal protein kinase pathway in the cellular response to Adriamycin and other chemotherapeutic drugs. J. Biol. Chem., 271: 30950-30955, 1996.
21. Potapova, O., Haghighi, A., Bost, F., Liu, C., Birrer, M. J., Gjerset, R., and Mercola, D. The Jun kinase/stress-activated protein kinase pathway functions to regulate DNA repair and inhibition of the pathway sensitizes tumor cells to cisplatin. J. Biol. Chem., 272: 14041-14044, 1997.
22. Chen, Y-R., Wang, X., Templeton, D., Davis, R. J., and Tan, T-H. The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and gamma radiation: duration of JNK activation may determine cell death and proliferation. J. Biol. Chem., 271: 31929-31936, 1996.
23. Verheij, M., Bose, R., Lin, X. H., Yao, B., Jarvis, W. D., Grant, S., Birrer, M. J., Szabo, E., Zon, L. I., Kyriakis, J. M., Haimovitz-Friedman, A., Fuks, Z., and Kolesnick, R. N. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature (Lond.), 380: 75-79, 1996.
24. Zanke, B. W., Boudreau, K., Robie, E., Winnett, E., Tibbles, L. A., Zon, L., Kyriakis, J., Liu, F. F., and Woodgett, J. R. The stress-activated protein kinase pathway mediates cell death following injury induced by cis-platinum, UV irradiation or heat. Curr. Biol., 6: 606-613, 1996.
25. Kim, T., Kim, T. Y., Song, Y-H., Min, I. M., Yim, J., and Kim, T. K. Activation of interferon regulatory factor 3 in response to DNA-damaging agents. J. Biol. Chem., 274: 30686-30689, 1999.
26. Tamura, T., Ishihara, M., Lamphier, M. S., Tanaka, N., Oishi, I., Aizawa, S., Matsuyama, T., Mak, T. W., Taki, S., and Taniguchi, T. An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes. Nature (Lond.), 376: 596-599, 1995.
27. Tanaka, N., Ishihara, M., Lampier, M. S., Nozawa, H., Matsuyama, T., Mak, T. W., Aizawa, S., Tokino, T., Oren, M., and Taniguchi, T. Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage. Nature (Lond.), 382: 816-818, 1996.